Literature DB >> 27707716

80% of China's clinical trial data are fraudulent, investigation finds.

Michael Woodhead1.   

Abstract

Mesh：

Year:  2016        PMID： 27707716     DOI： 10.1136/bmj.i5396

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis.

Authors:  Stefan Leucht; Anna Chaimani; Dimitris Mavridis; Claudia Leucht; Maximilian Huhn; Bartosz Helfer; Myrto Samara; Andrea Cipriani; John R Geddes; John M Davis
Journal:  Neuropsychopharmacology       Date:  2019-06-18       Impact factor: 7.853

Review 2.  Beds, overlays and mattresses for preventing and treating pressure ulcers: an overview of Cochrane Reviews and network meta-analysis.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Elizabeth McInnes; En Lin Goh; Gill Norman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-16

Review 3.  Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.

Authors:  Irene Bighelli; Alessandro Rodolico; Spyridon Siafis; Myrto T Samara; Wulf-Peter Hansen; Salvatore Salomone; Eugenio Aguglia; Pierfelice Cutrufelli; Ingrid Bauer; Lio Baeckers; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

Review 4.  Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés.

Authors:  Jerome Sarris; Wolfgang Marx; Melanie M Ashton; Chee H Ng; Nicole Galvao-Coelho; Zahra Ayati; Zhang-Jin Zhang; Siegfried Kasper; Arun Ravindran; Brian H Harvey; Adrian Lopresti; David Mischoulon; Jay Amsterdam; Lakshmi N Yatham; Michael Berk
Journal:  Can J Psychiatry       Date:  2021-02-18       Impact factor: 4.356

5.  Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.

Authors:  Beatrice Mainoli; Tiago Machado; Gonçalo S Duarte; Luísa Prada; Nilza Gonçalves; Joaquim J Ferreira; João Costa
Journal:  BMC Med Res Methodol       Date:  2021-02-26       Impact factor: 4.615

6.  Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yuji Okuyama; Kazuto Oya; Shinji Matsunaga; Taro Kishi; Nakao Iwata
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-15       Impact factor: 2.570

7.  How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis.

Authors:  Katharina Gutsmiedl; Marc Krause; Irene Bighelli; Johannes Schneider-Thoma; Stefan Leucht
Journal:  BMC Psychiatry       Date:  2020-03-04       Impact factor: 3.630

8.  Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials.

Authors:  Irene Bighelli; Georgia Salanti; Cornelia Reitmeir; Sofia Wallis; Corrado Barbui; Toshi A Furukawa; Stefan Leucht
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

Review 9.  Support surfaces for pressure ulcer prevention: A network meta-analysis.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

10.  Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study.

Authors:  Zheng Tong; Fangzhou Li; Yusuke Ogawa; Norio Watanabe; Toshi A Furukawa
Journal:  BMC Med Res Methodol       Date:  2018-09-24       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.